Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 6:44 PM View:  | Revance Therapeutics, Inc. (RVNC) | 18-Mar-24 | Sale | 8,125 | $5.04 | $40,971.10 | (6%) 145.94K to 137.81K | |
| 19-Mar-24 6:44 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-24 | Payment of Exercise | 3,269 | $5.30 | $17,342.00 | (2%) 149.21K to 145.94K | |
| 04-Mar-24 5:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Feb-24 | Grant | 15,143 | -- | -- | 11% 134.07K to 149.21K | |
| 02-Feb-24 4:48 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Jan-24 | Grant | 90,000 | -- | -- | 204% 44.07K to 134.07K | |
| 07-Sep-23 5:37 PM View: | Revance Therapeutics, Inc. (RVNC) | 06-Sep-23 | Sale (Planned) | 11,000 | $17.06 | $187,704.00 | (20%) 55.07K to 44.07K | |
| 07-Sep-23 5:37 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-Sep-23 | Private Sale (Planned) | 23,853 | $17.81 | $424,920.00 | (30%) 78.92K to 55.07K | |
| 15-Aug-23 4:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Grant | 19,346 | -- | -- | 28% 69.17K to 88.51K | |
| 15-Aug-23 4:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Payment of Exercise | 9,592 | $18.91 | $181,385.00 | (11%) 88.51K to 78.92K | |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-May-23 | Sale | 21,401 | $34.55 | $739,338.00 | (24%) 90.57K to 69.17K | |
| 17-Mar-23 3:21 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-23 | Payment of Exercise | 7,330 | $30.65 | $224,664.00 | (13%) 55.55K to 48.22K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Mar-23 | Sale | 18,496 | $31.59 | $584,220.00 | (25%) 74.04K to 55.55K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Sep-22 | Grant | 42,349 | -- | -- | 134% 31.69K to 74.04K | |
| 16-Sep-22 4:55 PM View: | Revance Therapeutics, Inc. (RVNC) | 14-Sep-22 | Private Sale (Planned) | 11,000 | $27.07 | $297,798.00 | (26%) 42.69K to 31.69K | |
| 17-Mar-22 5:52 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-22 | Payment of Exercise | 5,110 | $15.79 | $80,686.90 | (11%) 47.8K to 42.69K | 2% |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-22 | Grant | 42,349 | -- | -- | 88% 48.22K to 90.57K | |
| 28-Sep-21 9:23 PM View: | Revance Therapeutics, Inc. (RVNC) | 27-Sep-21 | Market Sale (Planned) | 1,675 | $30.00 | $50,250.00 | (3%) 49.48K to 47.8K | 1% |
| 17-Mar-21 7:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-21 | Payment of Exercise | 2,881 | $27.73 | $79,890.10 | (6%) 52.36K to 49.48K | (< 1%) |
| 04-Feb-21 9:12 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-21 | Grant | 19,346 | -- | -- | 59% 33.01K to 52.36K | |
| 02-Oct-20 8:30 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Grant | 12,250 | -- | -- | 49% 25.0K to 37.25K | |
| 02-Oct-20 8:30 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Payment of Exercise | 4,236 | $25.14 | $106,493.00 | (11%) 37.25K to 33.01K | (10%) |
| 19-Feb-20 8:18 PM View: | Revance Therapeutics, Inc. (RVNC) | 18-Feb-20 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K |